Jan 15- A U.S. jury strengthened Edwards Lifesciences Corp's efforts to protect sales of the company's transcatheter heart valve implants, by ruling that a competing product from Medtronic Inc infringes its patent.
Most stocks that ended 2013 in negative territory did so for a reason. However, sometimes those reasons change.
Early in January, pros take a long hard look at the worst performing stocks from the previous year. What does Jim Cramer see?
NEW YORK, Dec 9- U.S. stocks edged higher on Monday, with the S&P 500 closing at a record high, as traders awaited more clues from the Federal Reserve on whether the U.S. central bank would soon begin winding down its economic stimulus. The Dow industrials traded within 43.11 points from session high to intraday low, in the Dow's tightest daily range since Aug. 17, 2012.
some of Monday midday movers:
Nov 19- Medtronic Inc reported higher quarterly earnings on Tuesday as stronger sales of its implantable devices to treat abnormal heart rhythms offset weakness in its spinal products business.
Nov 19- Medtronic Inc on Tuesday reported higher quarterly earnings that were slightly above analysts' expectations on stronger sales of its implantable devices to treat abnormal heart rhythms. Medtronic, a maker of pacemakers, insulin pumps and other medical devices, said most of its businesses were performing in line with or better than the overall market.
*Seeking U.S. partners, cites J&J, Medtronic, St Jude, Edwards. The French company is also seeking a partner in the United States to enter the world's largest healthcare market, and is in contact with Johnson& Johnson, Medtronic, St Jude Medical and Edwards Lifesciences, Marcello Conviti said.
"Mad Money" host Jim Cramer made calls on stocks viewers asked about.
Medtronic is preparing to launch the product in the United States, pending regulatory approval. Medtronic said it expects to launch the product in the United States for use in extreme-risk patients before its fiscal year ends in April 2014, noting that the U.S. Food and Drug Administration determined it has sufficient information to evaluate the device.
Stocks were slightly higher Monday, with the S&P 500 pushing to a fresh high, but gains were limited as investors digested a batch of mixed earnings reports and ahead of the Federal Reserve's policy-setting meeting.
Oct 28- Edwards Lifesciences Corp on Monday reported higher-than-expected quarterly earnings, but investors were disappointed with the pace of U.S. sales of its newest artificial heart valves, sending its shares down more than 4 percent.
Take a look at some of Monday's midday movers:
While we view these results as good, we believe expectations heading into the quarter were relatively high, " BMO Capital Markets analyst Joanne Wuensch said in a note to clients. Edwards, based in Irvine, California, said its third-quarter net income rose to $77 million, or 68 cents per share, from $69 million, or 58 cents per share, a year earlier.
Oct 28- Edwards Lifesciences Corp on Monday reported higher-than-expected quarterly earnings as it benefited from strong sales of artificial heart valves that are implanted without major invasive surgery. Third-quarter net income rose to $77 million, or 68 cents per share, from $69 million, or 58 cents per share, a year earlier.
Oct 28- Edwards Lifesciences Corp on Monday reported higher third-quarter earnings on strong sales of its artificial heart valves that are implanted without major invasive surgery. Third-quarter net income was $77 million, or 68 cents per share, compared with $69 million, or 58 cents per share, a year earlier.
Technology's new home can be found in "Silicon Slopes," Utah.
The renowned buy and hold investor stressed buying and selling on news is not good strategy. "Everyone thinks they are advantaged by trading on news. They are not."
Take a look at some of Tuesdays midday movers.
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.